Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical validation of dried blood spot sampling for ribociclib level measurement
NL-OMON48374Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ribociclib in breast cancer, sponsored by Erasmus MC. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON48374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48374.